| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 04/14/2004 | EP1301522A4 Novel compounds and methods |
| 04/14/2004 | EP1200419B1 Aminothiazole derivatives and their use as crf receptor ligands |
| 04/14/2004 | EP1189583A4 Indole derivatives |
| 04/14/2004 | EP1073641B1 New substituted amides, their production and their use |
| 04/14/2004 | EP0948495B1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents |
| 04/14/2004 | EP0935465B1 Novel substituted imidazole compounds |
| 04/14/2004 | EP0707487B1 Methods and pharmaceutical compositions useful for treating neurological disorders |
| 04/14/2004 | CN1489590A Compounds specific to adenosine A1, A2, and A3 receptor and uses thereof |
| 04/14/2004 | CN1489588A Thiazolyl-oxazolyl-pyrrolyl-and imidazolyl-acid amide derivatives useful as inbibitors of PDE 4 isozymes |
| 04/14/2004 | CN1489583A Novel physiologically active substance |
| 04/14/2004 | CN1489581A 喹唑啉酮衍生物 Quinazolinone derivatives |
| 04/14/2004 | CN1489576A Cannabinod receptor ligands |
| 04/14/2004 | CN1489476A Method of preparing biological materials and preparation produced using same |
| 04/14/2004 | CN1489467A Pharmacentical formulation comprising pyrazolo[4,3-d] pyrimdine and endothelin receptor antagonists or thienopyrimidines and endothelin receptor antagonists |
| 04/14/2004 | CN1488350A Eye preparation for mulating prescription suitable for ciprofloxacin and use method thereof |
| 04/14/2004 | CN1145637C Thio-substituted peptides as inhibitors for metalloproteinases and tnfliberation |
| 04/14/2004 | CN1145615C Novel polyhydroxypyrazine derivatives, preparation and pharmaceutical compositions containing same |
| 04/13/2004 | US6720348 For therapy of diabetic neuropathy, diabetic nephropathy, diabetic cardiomyopathy, diabetic retinopathy, diabetic microangiopathy, diabetic macroangiopathy, cataracts and foot ulcers |
| 04/13/2004 | US6720346 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation |
| 04/13/2004 | US6720342 Azabicyclic compounds used in treating a disease in the central nervous system caused by malfunctioning of the muscarinic cholinergic system. |
| 04/13/2004 | US6720327 Lactone integrin antagonists |
| 04/13/2004 | US6720315 Dihydrostilbene alkanoic acid derivatives |
| 04/13/2004 | US6720314 Use of a vital dye for facilitating surgical procedures for cataract extraction |
| 04/13/2004 | US6719750 Non-linear (coil or z-shaped) body member body housing one or more substances and a delivery mechanism for the sustained delivery of the one or more substances from the non-linear shaped body member to the patient |
| 04/08/2004 | WO2004029041A1 Novel piperidine derivatives for use in the treatment of chemokine mediated disease states |
| 04/08/2004 | WO2004028635A1 Ocular gene therapy |
| 04/08/2004 | WO2004028570A2 A method for treating severe tinnitus |
| 04/08/2004 | WO2004028537A1 Use of thiazolidinedione derivatives as aldose reductase inhibitors |
| 04/08/2004 | WO2004028517A1 A method for treating severe tinnitus |
| 04/08/2004 | WO2004009072A3 Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies |
| 04/08/2004 | WO2004004599A3 Epa and dha enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia |
| 04/08/2004 | WO2004001004A3 Membrane associated tumor endothelium markers |
| 04/08/2004 | WO2004000205A3 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 04/08/2004 | WO2003092701A3 Substituted aminoalkanephosphonic acids for the treatment of neuropathic pain, affective and attention disorders, schizophrenia, tinnitus, myopia and other ocular disorders |
| 04/08/2004 | WO2003086314A3 Tyrosine kinase inhibitors |
| 04/08/2004 | WO2003066077A3 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
| 04/08/2004 | WO2002072541A3 Human grk7: new member of the human g-protein-coupled-receptor kinase family |
| 04/08/2004 | US20040068014 Medicinal compositions comprising diclofenac and ornoprostil |
| 04/08/2004 | US20040068005 Pharmaceutical combinations |
| 04/08/2004 | US20040067987 Antiarthritic agents; osteoporosis; anticancer agents |
| 04/08/2004 | US20040067979 N-bridged selective androgen receptor modulators and methods of use thereof |
| 04/08/2004 | US20040067946 Phthalatyinone-piperidino-derivatives as pde4 inhibitors |
| 04/08/2004 | US20040067943 Tryptase inhibitors |
| 04/08/2004 | US20040067928 Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof |
| 04/08/2004 | US20040067909 Eye drops |
| 04/08/2004 | US20040067891 Therapeutic and/or preventive agents for diseases due to retinal ischemia |
| 04/08/2004 | US20040067237 Using a rational selection of representative PspAs from various families of clades to produce broadly efficacious Pneumococcal vaccines |
| 04/08/2004 | CA2689424A1 Methods for treatment and/or prevention of retinal disease |
| 04/08/2004 | CA2497280A1 Novel piperidine derivatives for use in the treatment of chemokine mediated disease states |
| 04/07/2004 | EP1404860A2 Delivery system for nucleic acids |
| 04/07/2004 | EP1404703A2 G-protein coupled receptors |
| 04/07/2004 | EP1404676A1 Pyrrolopyrimidines as protein kinase inhibitors |
| 04/07/2004 | EP1404674A2 Quinuclidine-substituted heteroaromatic compounds as ligands at nicotinic acetylcholine receptors |
| 04/07/2004 | EP1404672A1 Tyrosine kinase inhibitors |
| 04/07/2004 | EP1404667A1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 04/07/2004 | EP1404650A1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments |
| 04/07/2004 | EP1404371A2 Peptide-based compounds for targeting intergin receptors |
| 04/07/2004 | EP1404359A2 Methods of treatment involving human mda-7 |
| 04/07/2004 | EP1404350A2 Proteins associated with cell growth, differentiation, and death |
| 04/07/2004 | EP1404343A2 Therapeutic combinations for the treatment of hormone deficiencies |
| 04/07/2004 | EP1404339A2 Method for treating fibrotic diseases or other indications vi |
| 04/07/2004 | EP1404330A1 Substituted 8-arylquinoline pde4 inhibitors |
| 04/07/2004 | EP1404308A1 Treatment of disorders secondary to organic impairments |
| 04/07/2004 | EP1404295A2 Sustained release drug delivery devices with coated drug cores |
| 04/07/2004 | EP1404264A2 Insert for the treatment of dry eye |
| 04/07/2004 | EP1404180A2 Peripheral blood fibrocytes differentiation pathway and migration to wound sites |
| 04/07/2004 | EP1404174A2 Anti-infective compositions for treating disordered tissue such as cold sores |
| 04/07/2004 | EP1128820B1 Pharmaceutical mixture comprising a combination of a profen and other active compounds |
| 04/07/2004 | EP0910370B1 Compositions comprising a nitrone compound for use in treating uveitis |
| 04/07/2004 | CN1487940A Lactam compounds and medicinal use thereof |
| 04/07/2004 | CN1487939A Amido ether substituted imidazoquinolines |
| 04/07/2004 | CN1487923A Process for the preparation of (3-cyano-1H-indol-7-yl) (4-(4-fluorophenethyl)piperazin-1-yl)-methanone and salts thereof |
| 04/07/2004 | CN1487841A Lentiviral vector-mediated gene transfer and uses thereof |
| 04/07/2004 | CN1487832A Novel method and compositions for local treatment of Meniere's disease, tinnitus and lor hearing loss |
| 04/07/2004 | CN1487831A Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mGluR1 antagonists |
| 04/07/2004 | CN1486701A Artificial tear |
| 04/07/2004 | CN1144875C OMP 26 antigen of haemophilus influenzae |
| 04/07/2004 | CN1144799C N-(iminomethyl) amine derivatives, their preparation, their use as medicines and medical compositions containing the same |
| 04/07/2004 | CN1144790C Telmisartan polymorphs, producing process thereof and use in prepn. of pharmaceutical composition thereof |
| 04/07/2004 | CN1144785C Hydroxamic acid and its preparation, and pharmaceutical composition |
| 04/06/2004 | US6716978 For therapy and prohylaxis of inflammatory diseases including joint inflammation, crohn's disease, and inflammatory bowel disease; respiratory diseases such as chronic obstructive pulmonary disease (copd) including asthma, chronic bronchitis |
| 04/06/2004 | US6716876 Cyclopentane(ENE)heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents |
| 04/06/2004 | US6716871 Cyclic AMP-specific phosphodie sterase inhibitors |
| 04/06/2004 | US6716849 Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect |
| 04/06/2004 | US6716847 Antiallergens, antiinflammatory |
| 04/06/2004 | US6716845 Barbituric acid derivatives |
| 04/06/2004 | US6716835 Use of diltiazem for treating retinal pathologies |
| 04/06/2004 | US6716828 Treatment or prevention of neural or cardiovascular tissue damage related to cerebral ischemia and reperfusion injury in an animal by administering poly(adp- ribose) polymerase (?parp?) inhibitors. |
| 04/06/2004 | US6716818 Caspase inhibitors and the use thereof |
| 04/06/2004 | US6716585 Detecting genes associated with controlling angiogenesis; obtain and culture endothelial cells, isolate ribonucleic acids, amplified or reduced concentrations of preferenial ribonucleic acids indicate association with angiogenesis |
| 04/06/2004 | US6716447 Stable carotene xanthophyll beadlet compositions and methods of use |
| 04/06/2004 | CA2060616C Use of 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine derivatives as free radical scavengers |
| 04/01/2004 | WO2004027033A2 Lentiviral vector-mediated gene transfer and uses thereof |
| 04/01/2004 | WO2004026874A1 Novel crystals of triazaspiro[5.5]undecane derivative |
| 04/01/2004 | WO2004026873A1 Triazaspiro[5.5]undecane derivatives and drugs comprising the same as the active ingredient |
| 04/01/2004 | WO2004026857A2 Methods of purifying cannabinoids from plant material |
| 04/01/2004 | WO2004026841A1 Novel 6-substituted uracil derivative and therapeutic agent for allergic disease |
| 04/01/2004 | WO2004026815A2 Phenol derivatives and their use as rotamase inhibitors |
| 04/01/2004 | WO2004026406A1 Use of cytokine synthesis inhibitors for the treatment of dry eye disorders |
| 04/01/2004 | WO2004026320A1 Vitreoretinal tamponades based on fluorosilicone fluids |